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Although vitiligo is characterized 
by macules devoid of melanin 
pigment and identifiable 
melanocytes, previous 
observations predicted 
that this disease stems from 
melanocyte detachment and 
subsequent transepidermal 
loss. In a combined family-
based and case–control 
association analysis, Silva de 
Castro and colleagues found 
an age-dependent association 
between vitiligo and variants of 
the discoidin domain receptor 
1 (DDR1) gene in a population 
of family trios from southern 
Brazil. In support of this finding, 
inhibition of this gene product 
with imatinib has previously 
been shown to lead to vitiligo-
like lesions. These results 
suggest that harboring DDR1 
susceptibility variants may result 
in altered melanocyte adhesion 
to the basement membrane and 
consequent local melanocyte 
disappearance, especially at sites 
of trauma. See page 1813
Tools of the Trade
Histological evaluation of 
melanocytic lesions for diagnosis 
of cutaneous melanoma 
is subject to substantial 
differences in opinion 
between dermatopathologists. 
Alexandrescu and colleagues 
sought to develop an adjunct 
RT-PCR assay using melanoma-
specific markers to differentiate 
melanoma from nonmelanoma 
lesions in paraffin-embedded 
tissues based on the results of 
prior microarray studies. The 
silver homolog SILV proved 
to be the most useful marker 
with the greatest potential for 
improving melanoma diagnosis. 
See page 1887
Not Just Pigment
Loss-of-function mutations at the melanocortin 1 
receptor (MC1R) locus result in the fair skin phe-
notype, which is sensitive to the harmful effects of 
UVR. Although a reduction in eumelanin and the 
increase in pheomelanin are likely causative fac-
tors in this susceptibility, the exact mechanisms of 
MCR1 loss have not been elucidated. Robinson 
and colleagues utilized a novel mouse model to 
determine that MC1R photoprotection involves 
both pigmentary and nonpigmentary mechanisms 
in vivo. In addition, the pheomelanin/eumelanin 
ratio that results from loss of MC1R function appears to be photoprotective, as opposed to 
phototoxic, which was previously assumed to be the case. See page 1904
European Perspective
In a descriptive epidemiological study, Holterhues 
and colleagues analyzed 356,620 cutaneous malig-
nancies from the 1989–2005 Netherlands Cancer 
Registry data set in order to determine the abso-
lute numbers and incidence rates of all skin cancer 
groups. This analysis revealed that keratinocytic 
cancers (basal cell carcinoma and squamous cell 
carcinoma) and melanoma comprise the vast major-
ity of cutaneous malignancies, and the remaining 
2% are primarily lymphomas, dermatofibrosarcoma 
protuberans, appendageal tumors, and Merkel cell 
carcinomas. Interestingly, the UV-related skin can-
cers increased significantly over the period, and at 
a higher rate than other skin malignancies, confirm-
ing that changes in UV-exposure patterns are likely 
to be driving the steep increase. See page 1807
Exclusive Epitopes
Although 30–60% of chronic idiopathic 
urticaria (CIU) patients have autoantibodies 
against the α-subunit of the high-affinity IgE 
receptor (FcεRIα) or IgE on mast cells, the 
relationship between CIU and Hashimoto’s 
thyroiditis (HT), which involves autoantibod-
ies to thyroglobulin or thyroid peroxidase 
in 30% of CIU patients, remains unknown. 
Mozena and colleagues developed an 
immortalized human mast cell line (called 
LUVA) that displays high FcεRI concentra-
tions and is activated upon incubation with CIU serum. This system confirmed the high 
prevalence of thyroid antibodies and anti-FcεRI antibodies in CIU and demonstrated a 
lack of epitope cross-reactivity between these autoantibodies. These results suggest that 
the co-occurrence of CIU and HT stems from a shared genetic predisposition to auto-
immune disorders. See page 1860
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